DK1183247T3 - Polycycliske thiazolsystemer, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser - Google Patents

Polycycliske thiazolsystemer, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser

Info

Publication number
DK1183247T3
DK1183247T3 DK00902658T DK00902658T DK1183247T3 DK 1183247 T3 DK1183247 T3 DK 1183247T3 DK 00902658 T DK00902658 T DK 00902658T DK 00902658 T DK00902658 T DK 00902658T DK 1183247 T3 DK1183247 T3 DK 1183247T3
Authority
DK
Denmark
Prior art keywords
compounds
processes
preparation
drugs containing
thiazole systems
Prior art date
Application number
DK00902658T
Other languages
English (en)
Inventor
Gerhard Jaehne
Karl Geisen
Hans-Jochen Lang
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1183247T3 publication Critical patent/DK1183247T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84Naphthothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00902658T 1999-02-26 2000-02-05 Polycycliske thiazolsystemer, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser DK1183247T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908533A DE19908533A1 (de) 1999-02-26 1999-02-26 Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
PCT/EP2000/000927 WO2000051997A1 (de) 1999-02-26 2000-02-05 Polycyclische thiazol-systeme und ihre verwendung als anorektika

Publications (1)

Publication Number Publication Date
DK1183247T3 true DK1183247T3 (da) 2005-09-19

Family

ID=7899078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902658T DK1183247T3 (da) 1999-02-26 2000-02-05 Polycycliske thiazolsystemer, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser

Country Status (19)

Country Link
US (1) US6187801B1 (da)
EP (1) EP1183247B1 (da)
JP (1) JP4728485B2 (da)
KR (1) KR20020000545A (da)
CN (1) CN1149205C (da)
AT (1) ATE296295T1 (da)
AU (1) AU762802B2 (da)
BR (1) BR0008511A (da)
CA (1) CA2364903A1 (da)
CO (1) CO5180595A1 (da)
DE (2) DE19908533A1 (da)
DK (1) DK1183247T3 (da)
ES (1) ES2241574T3 (da)
HK (1) HK1042300B (da)
MY (1) MY133195A (da)
PT (1) PT1183247E (da)
TW (1) TW593294B (da)
WO (1) WO2000051997A1 (da)
ZA (1) ZA200106440B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
NZ520981A (en) * 2000-02-26 2004-08-27 Aventis Pharma Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
DE10142663B4 (de) * 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-ol-Systeme
KR100712171B1 (ko) * 2004-09-17 2007-05-02 김진우 폐타이어를 이용한 조립식 배관블록
MX2010010659A (es) * 2008-03-31 2010-10-26 Genentech Inc Compuestos de benzopirano y benzoxepina, inhibidores de fosfoinoinositida 3-cinasas y metodos para utilizarlos.
US8263633B2 (en) 2009-09-28 2012-09-11 F. Hoffman-La Roche Ag Benzoxepin PI3K inhibitor compounds and methods of use
MY160064A (en) 2009-09-28 2017-02-15 Hoffmann La Roche Benzoxazepin pi3k inhibitor compounds and methods of use
US9090628B2 (en) 2011-03-21 2015-07-28 Genentech, Inc. Benzoxazepin compounds selective for PI3K P110 delta and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
EP0749966A4 (en) * 1994-03-11 1997-07-02 Yamanouchi Pharma Co Ltd 5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT
JPH1179993A (ja) * 1997-09-05 1999-03-23 Sumitomo Pharmaceut Co Ltd 免疫抑制剤
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Also Published As

Publication number Publication date
DE19908533A1 (de) 2000-08-31
CO5180595A1 (es) 2002-07-30
ATE296295T1 (de) 2005-06-15
US6187801B1 (en) 2001-02-13
HK1042300B (zh) 2004-12-10
HK1042300A1 (en) 2002-08-09
DE50010403D1 (de) 2005-06-30
PT1183247E (pt) 2005-07-29
CN1149205C (zh) 2004-05-12
JP2002538150A (ja) 2002-11-12
BR0008511A (pt) 2002-04-02
WO2000051997A1 (de) 2000-09-08
CN1341108A (zh) 2002-03-20
AU2441600A (en) 2000-09-21
EP1183247B1 (de) 2005-05-25
ES2241574T3 (es) 2005-11-01
MY133195A (en) 2007-10-31
JP4728485B2 (ja) 2011-07-20
AU762802B2 (en) 2003-07-03
TW593294B (en) 2004-06-21
CA2364903A1 (en) 2000-09-08
EP1183247A1 (de) 2002-03-06
ZA200106440B (en) 2002-03-06
KR20020000545A (ko) 2002-01-05

Similar Documents

Publication Publication Date Title
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
BR0208338A (pt) Derivados de piridina
SE0301700D0 (sv) Novel compounds
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
SE9904505D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
TW200610527A (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
MY139102A (en) Substituted n-aryl heterocycles, process for their preparation and their use as medicaments
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
SE0104140D0 (sv) Novel Compounds
YU21401A (sh) Tetrahidropiridoetri
MXPA05008690A (es) Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
SE0302192D0 (sv) Novel compounds
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
IL159554A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
BR0208566A (pt) Derivados de beta-carbolina
NO20052794L (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
DK1183247T3 (da) Polycycliske thiazolsystemer, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser
SE0303280D0 (sv) Novel compounds
PT1157015E (pt) Utilizacao de sistemas 2-amino-triazole policiclicos para a preparacao de medicamentos para tratamento de perturbacoes lipometabolicas, da obesidade e da diabetes tipo ii
DK1173176T3 (da) Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas